array(40) {
  [0]=>
  string(4) "8158"
  ["article_id"]=>
  string(4) "8158"
  [1]=>
  string(56) "Even More Conferences Canceled Over Coronavirus Concerns"
  ["article_title"]=>
  string(56) "Even More Conferences Canceled Over Coronavirus Concerns"
  [2]=>
  string(153) "&#nlThe Joint meeting of the American College of Cardiology’s and World Congress of Cardiology (ACC.20/WCC)is the latest medtech/pharma"
  ["short_description"]=>
  string(153) "&#nlThe Joint meeting of the American College of Cardiology’s and World Congress of Cardiology (ACC.20/WCC)is the latest medtech/pharma"
  [3]=>
  string(3020) "&#nl
The Joint meeting of the American College of Cardiology’s and World Congress of Cardiology (ACC.20/WCC)is the latest medtech/pharma conference to be canceled over concerns of the spread of the coronavirus (COVID-19). The event was slated to occur March 28-30.
&#nl
Instead, the organization said virtual options for science and award presentations will be announced in the coming days.
&#nl
"The health, safety, and well-being of our members, staff, exhibitors, faculty and other stakeholders is of paramount importance," ACC President Richard J. Kovacs, MD, FACC, said in a release. "With an ever-increasing number of ACC members on the front lines of preparing and reacting to the COVID-19 outbreak, it is in the best interest of everyone to cancel the meeting and ensure our members are able to do what they do best – help and heal."
&#nl
ACC’s annual meeting joins several other high-profile conferences that have been canceled because of fears of the spread of the coronavirus. Last week both Healthcare Information and Management Systems Society (HIMSS) and South by Southwest (SXSW) announced cancelations heeding the CDC’s recommendations.
&#nl
The COVID-19 crisis opens up opportunities for healthcare media companies such as Evermed to help with digital and virtual alternatives.
&#nl
“Growing concerns about COVID-19 have led to 30% to 50% of participants canceling their participation at some of the large annual scientific conferences,” Cass Wheeler, former national CEO of the American Heart Association and senior advisor to Evermed, said in a release. “We expect some societies to cancel or postpone their entire annual conferences. This will lead to reduced opportunities for pharma and medical device companies to engage the global scientific community with their latest clinical trials and innovations to improve patient care. It will also create revenue gaps for the medical societies."
&#nl
Evermed said under its new Conference Response Strategy, medical societies can turn their annual conferences into global, digitally powered, multi-day events.
&#nl
To date, the number of coronavirus cases in the U.S. is now more than 550 and 22 people have died from the disease, according to a report on NBC News’s website.
"
  ["description"]=>
  string(3020) "&#nl
The Joint meeting of the American College of Cardiology’s and World Congress of Cardiology (ACC.20/WCC)is the latest medtech/pharma conference to be canceled over concerns of the spread of the coronavirus (COVID-19). The event was slated to occur March 28-30.
&#nl
Instead, the organization said virtual options for science and award presentations will be announced in the coming days.
&#nl
"The health, safety, and well-being of our members, staff, exhibitors, faculty and other stakeholders is of paramount importance," ACC President Richard J. Kovacs, MD, FACC, said in a release. "With an ever-increasing number of ACC members on the front lines of preparing and reacting to the COVID-19 outbreak, it is in the best interest of everyone to cancel the meeting and ensure our members are able to do what they do best – help and heal."
&#nl
ACC’s annual meeting joins several other high-profile conferences that have been canceled because of fears of the spread of the coronavirus. Last week both Healthcare Information and Management Systems Society (HIMSS) and South by Southwest (SXSW) announced cancelations heeding the CDC’s recommendations.
&#nl
The COVID-19 crisis opens up opportunities for healthcare media companies such as Evermed to help with digital and virtual alternatives.
&#nl
“Growing concerns about COVID-19 have led to 30% to 50% of participants canceling their participation at some of the large annual scientific conferences,” Cass Wheeler, former national CEO of the American Heart Association and senior advisor to Evermed, said in a release. “We expect some societies to cancel or postpone their entire annual conferences. This will lead to reduced opportunities for pharma and medical device companies to engage the global scientific community with their latest clinical trials and innovations to improve patient care. It will also create revenue gaps for the medical societies."
&#nl
Evermed said under its new Conference Response Strategy, medical societies can turn their annual conferences into global, digitally powered, multi-day events.
&#nl
To date, the number of coronavirus cases in the U.S. is now more than 550 and 22 people have died from the disease, according to a report on NBC News’s website.
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "40"
  ["rss_id"]=>
  string(2) "40"
  [14]=>
  string(83) "https://www.mddionline.com/even-more-conferences-canceled-over-coronavirus-concerns"
  ["blog_url"]=>
  string(83) "https://www.mddionline.com/even-more-conferences-canceled-over-coronavirus-concerns"
  [15]=>
  string(19) "2020-03-10 03:32:23"
  ["add_date"]=>
  string(19) "2020-03-10 03:32:23"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:24:03"
  ["create_at"]=>
  string(19) "2020-03-11 16:24:03"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8101"
  ["article_id"]=>
  string(4) "8101"
  [1]=>
  string(63) "Robots that admit mistakes foster better conversation in humans"
  ["article_title"]=>
  string(63) "Robots that admit mistakes foster better conversation in humans"
  [2]=>
  string(150) "A new study showed that the humans on teams that included a robot expressing vulnerability communicated more with each other and later reported having"
  ["short_description"]=>
  string(150) "A new study showed that the humans on teams that included a robot expressing vulnerability communicated more with each other and later reported having"
  [3]=>
  string(303) "A new study showed that the humans on teams that included a robot expressing vulnerability communicated more with each other and later reported having a more positive group experience than people teamed with silent robots or with robots that made neutral statements, like reciting the game's score. "
  ["description"]=>
  string(303) "A new study showed that the humans on teams that included a robot expressing vulnerability communicated more with each other and later reported having a more positive group experience than people teamed with silent robots or with robots that made neutral statements, like reciting the game's score. "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "29"
  ["rss_id"]=>
  string(2) "29"
  [14]=>
  string(62) "https://www.sciencedaily.com/releases/2020/03/200309152047.htm"
  ["blog_url"]=>
  string(62) "https://www.sciencedaily.com/releases/2020/03/200309152047.htm"
  [15]=>
  string(19) "2020-03-10 03:20:47"
  ["add_date"]=>
  string(19) "2020-03-10 03:20:47"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:23:52"
  ["create_at"]=>
  string(19) "2020-03-11 16:23:52"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8003"
  ["article_id"]=>
  string(4) "8003"
  [1]=>
  string(49) "2018 Health Care Spending Up Due to Higher Prices"
  ["article_title"]=>
  string(49) "2018 Health Care Spending Up Due to Higher Prices"
  [2]=>
  string(150) "MONDAY, March 9, 2020 -- Average employer-sponsored insurance spending rose to $5,892 per person in 2018, according to the Health Care Cost Institute "
  ["short_description"]=>
  string(150) "MONDAY, March 9, 2020 -- Average employer-sponsored insurance spending rose to $5,892 per person in 2018, according to the Health Care Cost Institute "
  [3]=>
  string(250) "MONDAY, March 9, 2020 -- Average employer-sponsored insurance spending rose to $5,892 per person in 2018, according to the Health Care Cost Institute annual Health Care Cost and Utilization Report.&#nlTo assess the trends within four categories of..."
  ["description"]=>
  string(250) "MONDAY, March 9, 2020 -- Average employer-sponsored insurance spending rose to $5,892 per person in 2018, according to the Health Care Cost Institute annual Health Care Cost and Utilization Report.&#nlTo assess the trends within four categories of..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(177) "https://www.drugs.com/news/2018-health-care-spending-up-due-higher-prices-88827.html?utm_source=ddc&utm_medium=rss&utm_campaign=2018+Health+Care+Spending+Up+Due+to+Higher+Prices"
  ["blog_url"]=>
  string(177) "https://www.drugs.com/news/2018-health-care-spending-up-due-higher-prices-88827.html?utm_source=ddc&utm_medium=rss&utm_campaign=2018+Health+Care+Spending+Up+Due+to+Higher+Prices"
  [15]=>
  string(19) "2020-03-10 03:00:33"
  ["add_date"]=>
  string(19) "2020-03-10 03:00:33"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:18:16"
  ["create_at"]=>
  string(19) "2020-03-11 16:18:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8004"
  ["article_id"]=>
  string(4) "8004"
  [1]=>
  string(73) "Amid COVID-19 Outbreak, State Dept Cautions Against Travel by Cruise Ship"
  ["article_title"]=>
  string(73) "Amid COVID-19 Outbreak, State Dept Cautions Against Travel by Cruise Ship"
  [2]=>
  string(150) "MONDAY, March 9, 2020 -- As the number of U.S. COVID-19 cases climbed past 530 in at least 34 states and the death toll hit 22, the State Department i"
  ["short_description"]=>
  string(150) "MONDAY, March 9, 2020 -- As the number of U.S. COVID-19 cases climbed past 530 in at least 34 states and the death toll hit 22, the State Department i"
  [3]=>
  string(249) "MONDAY, March 9, 2020 -- As the number of U.S. COVID-19 cases climbed past 530 in at least 34 states and the death toll hit 22, the State Department issued an advisory Sunday that urged all Americans to avoid cruise travel.&#nl"U.S. citizens,..."
  ["description"]=>
  string(249) "MONDAY, March 9, 2020 -- As the number of U.S. COVID-19 cases climbed past 530 in at least 34 states and the death toll hit 22, the State Department issued an advisory Sunday that urged all Americans to avoid cruise travel.&#nl"U.S. citizens,..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(226) "https://www.drugs.com/news/amid-covid-19-outbreak-state-dept-cautions-against-travel-cruise-ship-88828.html?utm_source=ddc&utm_medium=rss&utm_campaign=Amid+COVID-19+Outbreak%2C+State+Dept+Cautions+Against+Travel+by+Cruise+Ship"
  ["blog_url"]=>
  string(226) "https://www.drugs.com/news/amid-covid-19-outbreak-state-dept-cautions-against-travel-cruise-ship-88828.html?utm_source=ddc&utm_medium=rss&utm_campaign=Amid+COVID-19+Outbreak%2C+State+Dept+Cautions+Against+Travel+by+Cruise+Ship"
  [15]=>
  string(19) "2020-03-10 03:00:12"
  ["add_date"]=>
  string(19) "2020-03-10 03:00:12"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:18:16"
  ["create_at"]=>
  string(19) "2020-03-11 16:18:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8065"
  ["article_id"]=>
  string(4) "8065"
  [1]=>
  string(67) "LHC Group announces response and efforts to confront COVID-19 virus"
  ["article_title"]=>
  string(67) "LHC Group announces response and efforts to confront COVID-19 virus"
  [2]=>
  string(150) "LAFAYETTE, La., March  09, 2020  (GLOBE NEWSWIRE) -- In response to the growing number of confirmed COVID-19 (coronavirus) cases across the U.S., LHC "
  ["short_description"]=>
  string(150) "LAFAYETTE, La., March  09, 2020  (GLOBE NEWSWIRE) -- In response to the growing number of confirmed COVID-19 (coronavirus) cases across the U.S., LHC "
  [3]=>
  string(410) "
LAFAYETTE, La., March  09, 2020  (GLOBE NEWSWIRE) -- In response to the growing number of confirmed COVID-19 (coronavirus) cases across the U.S., LHC Group, Inc. (NASDAQ: LHCG) has established an internal multi-disciplinary COVID-19 task force to organize resources and coordinate efforts as the company joins the nation’s healthcare industry in confronting the virus.
"
  ["description"]=>
  string(410) "
LAFAYETTE, La., March  09, 2020  (GLOBE NEWSWIRE) -- In response to the growing number of confirmed COVID-19 (coronavirus) cases across the U.S., LHC Group, Inc. (NASDAQ: LHCG) has established an internal multi-disciplinary COVID-19 task force to organize resources and coordinate efforts as the company joins the nation’s healthcare industry in confronting the virus.
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "26"
  ["rss_id"]=>
  string(2) "26"
  [14]=>
  string(138) "http://www.globenewswire.com/news-release/2020/03/09/1997452/0/en/LHC-Group-announces-response-and-efforts-to-confront-COVID-19-virus.html"
  ["blog_url"]=>
  string(138) "http://www.globenewswire.com/news-release/2020/03/09/1997452/0/en/LHC-Group-announces-response-and-efforts-to-confront-COVID-19-virus.html"
  [15]=>
  string(19) "2020-03-10 02:30:00"
  ["add_date"]=>
  string(19) "2020-03-10 02:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:23:41"
  ["create_at"]=>
  string(19) "2020-03-11 16:23:41"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8204"
  ["article_id"]=>
  string(4) "8204"
  [1]=>
  string(82) "DrFirst and GoHipo partner to combat substance abuse relapse via mobile telehealth"
  ["article_title"]=>
  string(82) "DrFirst and GoHipo partner to combat substance abuse relapse via mobile telehealth"
  [2]=>
  string(150) "Mobile app equipped with social media and telemedicine designed to keep patients in recovery connected with their clinical-care teams and support netw"
  ["short_description"]=>
  string(150) "Mobile app equipped with social media and telemedicine designed to keep patients in recovery connected with their clinical-care teams and support netw"
  [3]=>
  string(175) "Mobile app equipped with social media and telemedicine designed to keep patients in recovery connected with their clinical-care teams and support networks after discharge.&#nl"
  ["description"]=>
  string(175) "Mobile app equipped with social media and telemedicine designed to keep patients in recovery connected with their clinical-care teams and support networks after discharge.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(113) "https://www.healthcareitnews.com/news/drfirst-and-gohipo-partner-combat-substance-abuse-relapse-mobile-telehealth"
  ["blog_url"]=>
  string(113) "https://www.healthcareitnews.com/news/drfirst-and-gohipo-partner-combat-substance-abuse-relapse-mobile-telehealth"
  [15]=>
  string(19) "2020-03-10 01:57:03"
  ["add_date"]=>
  string(19) "2020-03-10 01:57:03"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:24:15"
  ["create_at"]=>
  string(19) "2020-03-11 16:24:15"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8159"
  ["article_id"]=>
  string(4) "8159"
  [1]=>
  string(64) "NeuroPace Removes Barrier for Epilepsy Treatment Through FDA Nod"
  ["article_title"]=>
  string(64) "NeuroPace Removes Barrier for Epilepsy Treatment Through FDA Nod"
  [2]=>
  string(153) "&#nlNeuroPace is spicing up the neuromodulation market a bit with a new nod from FDA for MRI labeling for the RNS system. The Mountain View, CA-based com"
  ["short_description"]=>
  string(153) "&#nlNeuroPace is spicing up the neuromodulation market a bit with a new nod from FDA for MRI labeling for the RNS system. The Mountain View, CA-based com"
  [3]=>
  string(3174) "&#nl
NeuroPace is spicing up the neuromodulation market a bit with a new nod from FDA for MRI labeling for the RNS system. The Mountain View, CA-based company’s RNS System treats patients living with seizures that do not respond to medication and first landed a PMA in November of 2013.
&#nl
In a release, the company said individuals with focal onset seizures that also have brain anomalies that require monitoring, such as tuberous sclerosis, brain tumors or multiple sclerosis, as well as those with non-brain MRI requirements, can now be offered the RNS System as a treatment option.
&#nl
The company added this will also allow people to receive the RNS System before committing to an irreversible surgery such as laser ablation while keeping their future treatment options open.
&#nl
“MRI conditional labeling opens up valuable medical imaging possibilities for our patients treated with the model RNS-320 neurostimulator, who can now receive full-body 1.5T magnetic resonance imaging (MRI) scans under appropriate conditions,” Michael Favet, President and CEO of NeuroPace, said in a release. “I’m pleased that we have removed a potential barrier to treatment and increased the number of patients who can benefit from this life-changing therapy.”
&#nl
The RNS System is a closed-loop, brain-responsive neurostimulation system that was designed to prevent epileptic seizures by stopping them at the source. The device uses a brain-computer interface that was designed to treat seizures by continuously monitoring brain waves to recognize each patient’s unique seizure onset fingerprint.
&#nl
It can probably be argued that NeuroPace’s RNS system entered new territory when the technology was evaluated in a clinical study from Stanford University to help treat obesity.
&#nl
There is evidence to suggest that long-term alterations in brain function, particularly in the reward and impulse control circuitry, occur with eating disorders, including loss-of-control eating. In addition, there is growing evidence to suggest that there are discrete changes in brain activity, or biomarkers, which immediately precede loss-of-control eating events.
&#nl
As part of the study, the RNS System will provide the first long-term ambulatory recordings of human brain activity from this key area of the reward circuit, the nucleus accumbens. Data captured by the system will be analyzed using artificial intelligence and machine learning to provide initial insights into the function of the human reward circuit as well as to initiate the development of algorithms that can individualize treatment in the future.
"
  ["description"]=>
  string(3174) "&#nl
NeuroPace is spicing up the neuromodulation market a bit with a new nod from FDA for MRI labeling for the RNS system. The Mountain View, CA-based company’s RNS System treats patients living with seizures that do not respond to medication and first landed a PMA in November of 2013.
&#nl
In a release, the company said individuals with focal onset seizures that also have brain anomalies that require monitoring, such as tuberous sclerosis, brain tumors or multiple sclerosis, as well as those with non-brain MRI requirements, can now be offered the RNS System as a treatment option.
&#nl
The company added this will also allow people to receive the RNS System before committing to an irreversible surgery such as laser ablation while keeping their future treatment options open.
&#nl
“MRI conditional labeling opens up valuable medical imaging possibilities for our patients treated with the model RNS-320 neurostimulator, who can now receive full-body 1.5T magnetic resonance imaging (MRI) scans under appropriate conditions,” Michael Favet, President and CEO of NeuroPace, said in a release. “I’m pleased that we have removed a potential barrier to treatment and increased the number of patients who can benefit from this life-changing therapy.”
&#nl
The RNS System is a closed-loop, brain-responsive neurostimulation system that was designed to prevent epileptic seizures by stopping them at the source. The device uses a brain-computer interface that was designed to treat seizures by continuously monitoring brain waves to recognize each patient’s unique seizure onset fingerprint.
&#nl
It can probably be argued that NeuroPace’s RNS system entered new territory when the technology was evaluated in a clinical study from Stanford University to help treat obesity.
&#nl
There is evidence to suggest that long-term alterations in brain function, particularly in the reward and impulse control circuitry, occur with eating disorders, including loss-of-control eating. In addition, there is growing evidence to suggest that there are discrete changes in brain activity, or biomarkers, which immediately precede loss-of-control eating events.
&#nl
As part of the study, the RNS System will provide the first long-term ambulatory recordings of human brain activity from this key area of the reward circuit, the nucleus accumbens. Data captured by the system will be analyzed using artificial intelligence and machine learning to provide initial insights into the function of the human reward circuit as well as to initiate the development of algorithms that can individualize treatment in the future.
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "40"
  ["rss_id"]=>
  string(2) "40"
  [14]=>
  string(87) "https://www.mddionline.com/neuropace-removes-barrier-epilepsy-treatment-through-fda-nod"
  ["blog_url"]=>
  string(87) "https://www.mddionline.com/neuropace-removes-barrier-epilepsy-treatment-through-fda-nod"
  [15]=>
  string(19) "2020-03-10 01:42:23"
  ["add_date"]=>
  string(19) "2020-03-10 01:42:23"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:24:03"
  ["create_at"]=>
  string(19) "2020-03-11 16:24:03"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8143"
  ["article_id"]=>
  string(4) "8143"
  [1]=>
  string(67) "Zentalis Leads a Trio of Biotechs Charting a Course for Wall Street"
  ["article_title"]=>
  string(67) "Zentalis Leads a Trio of Biotechs Charting a Course for Wall Street"
  [2]=>
  string(150) "Cell therapies and antibody drugs grab much of the attention and investment in cancer drug development but the scientists at Zentalis Pharmaceuticals "
  ["short_description"]=>
  string(150) "Cell therapies and antibody drugs grab much of the attention and investment in cancer drug development but the scientists at Zentalis Pharmaceuticals "
  [3]=>
  string(369) "Cell therapies and antibody drugs grab much of the attention and investment in cancer drug development but the scientists at Zentalis Pharmaceuticals contend that there’s a place for small molecules too. Now the biotech is preparing for an initial public stock offering to advance its pipeline, which includes a lead candidate in testing in combination […]"
  ["description"]=>
  string(369) "Cell therapies and antibody drugs grab much of the attention and investment in cancer drug development but the scientists at Zentalis Pharmaceuticals contend that there’s a place for small molecules too. Now the biotech is preparing for an initial public stock offering to advance its pipeline, which includes a lead candidate in testing in combination […]"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "36"
  ["rss_id"]=>
  string(2) "36"
  [14]=>
  string(108) "https://xconomy.com/new-york/2020/03/09/zentalis-leads-a-trio-of-biotechs-charting-a-course-for-wall-street/"
  ["blog_url"]=>
  string(108) "https://xconomy.com/new-york/2020/03/09/zentalis-leads-a-trio-of-biotechs-charting-a-course-for-wall-street/"
  [15]=>
  string(19) "2020-03-10 01:20:15"
  ["add_date"]=>
  string(19) "2020-03-10 01:20:15"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:23:57"
  ["create_at"]=>
  string(19) "2020-03-11 16:23:57"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8246"
  ["article_id"]=>
  string(4) "8246"
  [1]=>
  string(118) "First study identifies risk factors associated with death in adults hospitalized with new coronavirus disease in Wuhan"
  ["article_title"]=>
  string(118) "First study identifies risk factors associated with death in adults hospitalized with new coronavirus disease in Wuhan"
  [2]=>
  string(150) "Being of an older age, showing signs of sepsis, and having blood clotting issues when admitted to hospital are key risk factors associated with higher"
  ["short_description"]=>
  string(150) "Being of an older age, showing signs of sepsis, and having blood clotting issues when admitted to hospital are key risk factors associated with higher"
  [3]=>
  string(317) "Being of an older age, showing signs of sepsis, and having blood clotting issues when admitted to hospital are key risk factors associated with higher risk of death from the new coronavirus (COVID-19), according to a new observational study of 191 patients with confirmed COVID-19 from two hospitals in Wuhan, China. "
  ["description"]=>
  string(317) "Being of an older age, showing signs of sepsis, and having blood clotting issues when admitted to hospital are key risk factors associated with higher risk of death from the new coronavirus (COVID-19), according to a new observational study of 191 patients with confirmed COVID-19 from two hospitals in Wuhan, China. "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "29"
  ["rss_id"]=>
  string(2) "29"
  [14]=>
  string(62) "https://www.sciencedaily.com/releases/2020/03/200309130109.htm"
  ["blog_url"]=>
  string(62) "https://www.sciencedaily.com/releases/2020/03/200309130109.htm"
  [15]=>
  string(19) "2020-03-10 01:01:09"
  ["add_date"]=>
  string(19) "2020-03-10 01:01:09"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-12 15:56:02"
  ["create_at"]=>
  string(19) "2020-03-12 15:56:02"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8129"
  ["article_id"]=>
  string(4) "8129"
  [1]=>
  string(56) "Ship noise leaves crabs too stressed to hide from danger"
  ["article_title"]=>
  string(56) "Ship noise leaves crabs too stressed to hide from danger"
  [2]=>
  string(150) "The ocean is getting too loud even for crabs. Normally, shore crabs (Carcinus maenas) can slowly change their shell color to blend in with the rocky s"
  ["short_description"]=>
  string(150) "The ocean is getting too loud even for crabs. Normally, shore crabs (Carcinus maenas) can slowly change their shell color to blend in with the rocky s"
  [3]=>
  string(405) "The ocean is getting too loud even for crabs. Normally, shore crabs (Carcinus maenas) can slowly change their shell color to blend in with the rocky shore, but recent findings show that prolonged exposure to the sounds of ships weakens their camouflaging powers and leaves them more open to attack. The work illustrates how human-made undersea noise can turn shore crabs into sitting ducks for predators. "
  ["description"]=>
  string(405) "The ocean is getting too loud even for crabs. Normally, shore crabs (Carcinus maenas) can slowly change their shell color to blend in with the rocky shore, but recent findings show that prolonged exposure to the sounds of ships weakens their camouflaging powers and leaves them more open to attack. The work illustrates how human-made undersea noise can turn shore crabs into sitting ducks for predators. "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "34"
  ["rss_id"]=>
  string(2) "34"
  [14]=>
  string(62) "https://www.sciencedaily.com/releases/2020/03/200309130105.htm"
  ["blog_url"]=>
  string(62) "https://www.sciencedaily.com/releases/2020/03/200309130105.htm"
  [15]=>
  string(19) "2020-03-10 01:01:05"
  ["add_date"]=>
  string(19) "2020-03-10 01:01:05"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:23:57"
  ["create_at"]=>
  string(19) "2020-03-11 16:23:57"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8205"
  ["article_id"]=>
  string(4) "8205"
  [1]=>
  string(72) "Salesforce unveils new provider relationship management, analytics tools"
  ["article_title"]=>
  string(72) "Salesforce unveils new provider relationship management, analytics tools"
  [2]=>
  string(150) "The goal is to empower healthcare and life sciences organizations of all types and sizes to deliver more personalized and collaborative experiences at"
  ["short_description"]=>
  string(150) "The goal is to empower healthcare and life sciences organizations of all types and sizes to deliver more personalized and collaborative experiences at"
  [3]=>
  string(161) "The goal is to empower healthcare and life sciences organizations of all types and sizes to deliver more personalized and collaborative experiences at scale.&#nl"
  ["description"]=>
  string(161) "The goal is to empower healthcare and life sciences organizations of all types and sizes to deliver more personalized and collaborative experiences at scale.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(127) "https://www.healthcareitnews.com/news/salesforce-unveils-new-provider-relationship-mgmt-analytics-interoperability-technologies"
  ["blog_url"]=>
  string(127) "https://www.healthcareitnews.com/news/salesforce-unveils-new-provider-relationship-mgmt-analytics-interoperability-technologies"
  [15]=>
  string(19) "2020-03-10 00:55:31"
  ["add_date"]=>
  string(19) "2020-03-10 00:55:31"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:24:15"
  ["create_at"]=>
  string(19) "2020-03-11 16:24:15"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "7987"
  ["article_id"]=>
  string(4) "7987"
  [1]=>
  string(63) "It's Tough for Clinical Trial Participants to Learn Results"
  ["article_title"]=>
  string(63) "It's Tough for Clinical Trial Participants to Learn Results"
  [2]=>
  string(150) "MONDAY, March 9, 2020 -- Most clinical trial participants are not told the results of their study -- even though most people want to know, and researc"
  ["short_description"]=>
  string(150) "MONDAY, March 9, 2020 -- Most clinical trial participants are not told the results of their study -- even though most people want to know, and researc"
  [3]=>
  string(253) "MONDAY, March 9, 2020 -- Most clinical trial participants are not told the results of their study -- even though most people want to know, and researchers want to tell them.&#nlThe reason: Communication is a big barrier, a new study says. Simply put,..."
  ["description"]=>
  string(253) "MONDAY, March 9, 2020 -- Most clinical trial participants are not told the results of their study -- even though most people want to know, and researchers want to tell them.&#nlThe reason: Communication is a big barrier, a new study says. Simply put,..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "5"
  ["rss_id"]=>
  string(1) "5"
  [14]=>
  string(192) "https://www.drugs.com/news/s-tough-clinical-trial-participants-learn-results-88824.html?utm_source=ddc&utm_medium=rss&utm_campaign=It%27s+Tough+for+Clinical+Trial+Participants+to+Learn+Results"
  ["blog_url"]=>
  string(192) "https://www.drugs.com/news/s-tough-clinical-trial-participants-learn-results-88824.html?utm_source=ddc&utm_medium=rss&utm_campaign=It%27s+Tough+for+Clinical+Trial+Participants+to+Learn+Results"
  [15]=>
  string(19) "2020-03-10 00:03:43"
  ["add_date"]=>
  string(19) "2020-03-10 00:03:43"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:18:16"
  ["create_at"]=>
  string(19) "2020-03-11 16:18:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}